Eduardo Rene Salas - 20 Apr 2022 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Director
Signature
/s/ Lawrence J. Hineline, Attorney-in-fact
Issuer symbol
ITCI
Transactions as of
20 Apr 2022
Net transactions value
$0
Form type
4
Filing time
21 Apr 2022, 16:54:37 UTC
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 20 Apr 2022 Common Stock 20,000 $60.03 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.